Novel Drug Shows Promise for Inherited Blood Disorder

A novel drug called luspatercept may reduce blood transfusion burden for patients with transfusion-dependent beta-thalassemia, an inherited blood disorder.

Faculty Weigh in on the COVID-19 Response

There are variety of ways to improve care delivery, interpret new information, and maintain clinical trials and experiments in the face of the COVID-19 pandemic, according to recent editorials published by Feinberg faculty.

Genetic ‘Neighborhoods’ Fuel Leukemia

A new study has found that genetic alterations in a rare form of leukemia physically change the architecture of DNA, fueling the replication and spread of cancer cells.

Student Explores Decline in Opioid Prescriptions

Ben Smith, a second-year medical student, led a study that found opioid prescriptions in the emergency department declined significantly between 2013 and 2018.

Clinical Trial Begins at Northwestern Medicine for Patients with Severe COVID-19

Northwestern Medicine is enrolling patients in a global clinical trial of the drug sarilumab for hospitalized patients who are severely or critically ill with COVID-19.

Have an idea for the newsletter or a comment on this issue?